Use of antiepileptic drugs in hepatic and renal disease.
Asconapé JJ.
Handb Clin Neurol. 2014;119:417-32. doi: 10.1016/B978-0-7020-4086-3.00027-8.
Liver.
Piñeiro-Carrero VM, Piñeiro EO.
Pediatrics. 2004 Apr;113(4 Suppl):1097-106.
Free phenytoin toxicity.
Imam SH, Landry K, Kaul V, Gambhir H, John D, Kloss B.
Am J Emerg Med. 2014 Oct;32(10):1301.e3-4. doi: 10.1016/j.ajem.2014.03.036. Epub 2014 Apr 1.
Nitrofurantoin.
D'Arcy PF.
Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):540-7. doi: 10.1177/106002808501900706.
Phenytoin-induced dyskinesia: a case report.
Shah KC, Patel NS, Vasani P, Khadela A, Chavda VP, Vora L.
J Med Case Rep. 2023 Jul 21;17(1):313. doi: 10.1186/s13256-023-04033-6.
Needles in haystacks.
Reuben A.
Am J Gastroenterol. 2007 Nov;102(11):2444-6. doi: 10.1111/j.1572-0241.2007.01450.x.
Halothane hepatitis revisited.
Brown BR Jr.
N Engl J Med. 1985 Nov 21;313(21):1347-8. doi: 10.1056/NEJM198511213132108.
Phenytoin hepatotoxicity: a review of the literature.
Smythe MA, Umstead GS.
DICP. 1989 Jan;23(1):13-8. doi: 10.1177/106002808902300102.
Phenytoin and damage to the cerebellum - a systematic review of published cases.
Ferner R, Day R, Bradberry SM.
Expert Opin Drug Saf. 2022 Jul;21(7):957-977. doi: 10.1080/14740338.2022.2058487. Epub 2022 Apr 20.
Toxic-metabolic, nutritional, and medicinal-induced disorders of cerebellum.
Alekseeva N, McGee J, Kelley RE, Maghzi AH, Gonzalez-Toledo E, Minagar A.
Neurol Clin. 2014 Nov;32(4):901-11. doi: 10.1016/j.ncl.2014.07.001. Epub 2014 Sep 11.
